Zecyte 250 mg Tablet
  1. Home
  2. Pharma Products
  3. Cipla Ltd
  4. Zecyte 250 mg Tablet

Zecyte 250 mg Tablet

Zecyte 250 mg Tablet contains abiraterone acetate 250 mg, a hormonal anticancer medicine used for prostate cancer. It is an oral tablet taken according to the treatment plan prescribed by the oncologist. Abiraterone reduces androgen production, which can help slow the growth of prostate cancer cells.

BUY NOW

Category

Zecyte 250 mg Tablet is used in the treatment of advanced prostate cancer, including certain metastatic prostate cancer settings. Abiraterone acetate inhibits CYP17, an enzyme involved in androgen production, thereby reducing testosterone levels that can support prostate cancer growth. The medicine is generally used with a corticosteroid as directed by the treating oncologist. The dose, treatment duration, and monitoring requirements depend on the patient’s condition and prescribed treatment protocol.

Technical Specification

Specification Details
Active Ingredient Abiraterone Acetate
Strength 250 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 120 Tablets
Manufacturer/Marketer Cipla Ltd.

Product Also Known As

Zecyte 250 mg Tablet, Zecyte 250 Tablet, Zecyte Abiraterone Tablet, Abiraterone Acetate 250 mg Tablet, Abiraterone Prostate Cancer Tablet, Abiraterone Hormonal Anticancer Tablet